1 / 13

BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES.

BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002. Rationale for assessing,monitoring and evaluating the pharmaceutical situation in countries:. To get information and measure:

arden
Download Presentation

BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002

  2. Rationale for assessing,monitoring and evaluating the pharmaceutical situation in countries: To get information and measure: • the access to essential medicines for the population • the safety, efficacy and quality of medicines • the appropriateness of medicines use “If you don’t keep score … in a football or tennis match … you are only practising” – Jan Leschely.

  3. Assessment and monitoring: a tool • Countries: policy makers and managers • to assess performance of the sector (strong and weak points) • to assess capacity (structures, strategies and resources) • to set objectives and targets and decide about interventions • to synchronize health and other policies, e.g. trade; economical Does not tell the whole story; assist to a limited extent in understanding why a policy or strategy is successful or not.

  4. Assessment and monitoring: a tool • International Agencies / NGOs: • to assess performance and structure of the sector for developing new projects • to assess progress of projects • to assess impact of aid and assistance to policies

  5. Why is it important to use indicators? • Indicators allow a standardized measurement: • to compare situations within and between countries • to measure trends over time

  6. Indicator-based monitoring: Challenges • Selection of indicators adapted to a country context • Establish a sustainable system (assess & monitor): • systematic process that can be repeated over time • make resources available • institute a monitoring culture

  7. Core indicators: rationale • To obtain most relevant information from simple survey • 3 levels of indicators to be more specific and flexible • Rapid assessments with small samples and simple survey techniques • Measure of key information to provide a comprehensive picture • Enable systematic and standardised measurement methods • Allow regular, sustainable and cost-effective monitoring of NDPs

  8. Core indicators to monitor National Drug Policy Level I indicators (structure & process)  Questionnaire Level II indicators (outcome)  Systematic survey • Level III • WHO & MSH NDP indicators • Indicators for specific pharmaceutical components: • How to investigate drug use in health facilities; • Assessing regulatory capacity of countries. • Access indicators

  9. Level I core indicator on country pharmaceutical situation • To assess structures and processes in a national system • Questionnaire (key informants); no field survey • comparisons among countries • Key components National drug policy Essential drug list Financing & drug procurement Rational use of drugs Legislation and Regulation Quality assurance Production

  10. Level I: Example • Drug financing: • national public sector expenditure for drugs (MOH) • other public sector expenditure (insurance, local budget) • value of international drug aid • % of population covered by private/public insurance • dispensing policy: drugs free; user fees • Rational use: • EDL, Formulary Committees • Drug information Centre

  11. 4. Monitor 1. Assess 3.Implement 2. Plan Planned Interventions following assessment to address under performing areas undermining access to medicines:

  12. Future priorities • Strengthening National capacity of • Health systems • Human resources • through partnerships and collaboration for successful NDP implementation • National EDM Managers and WHO EDM offices and staff have a critical role to play - assessing and monitoring NDP • Monitor impact, reassess and adjust plans accordingto needs and performance.

  13. THANK YOU

More Related